Alexion lambasts NICE over rare disease rulingWatchdog accused of ignoring stakeholder consensus and call for negotiations Share XAlexion lambasts NICE over rare disease rulinghttps://pharmaphorum.com/news/alexion-lambasts-nice-over-rare-disease-ruling/
Rare disease drug Strensiq too expensive, says NICEAlexion’s new rare disease treatment Strensiq has been rejected by England’s health watchdog NICE in draft guidance. Strensiq Share XRare disease drug Strensiq too expensive, says NICEhttps://pharmaphorum.com/news/rare-disease-drug-strensiq-too-expensive-says-nice/